330 related articles for article (PubMed ID: 33548980)
1. Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy.
Nasser M; Ibrahim KMF; Elnabawi WM; Ahmed TM
Egypt J Immunol; 2020 Jun; 27(2):81-92. PubMed ID: 33548980
[TBL] [Abstract][Full Text] [Related]
2. Expression Level of Circulating Cell Free miR-155 Gene in Serum of Patients with Diabetic Nephropathy.
Akhbari M; Khalili M; Shahrabi-Farahani M; Biglari A; Bandarian F
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414764
[TBL] [Abstract][Full Text] [Related]
3. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
[TBL] [Abstract][Full Text] [Related]
4. Urinary IgG, serum CX3CL1 and miRNA-152-3p: as predictors of nephropathy in Egyptian type 2 diabetic patients.
Abdou AE; Anani HAA; Ibrahim HF; Ebrahem EE; Seliem N; Youssef EMI; Ghoraba NM; Hassan AS; Ramadan MAA; Mahmoud E; Issa S; Maghraby HM; Abdelrahman EK; Hassan HAM
Tissue Barriers; 2022 Jul; 10(3):1994823. PubMed ID: 34689723
[TBL] [Abstract][Full Text] [Related]
5. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
[TBL] [Abstract][Full Text] [Related]
6. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
Liu Q; Wang M; Xu T; Liang W; Yang F
J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
[TBL] [Abstract][Full Text] [Related]
7. Study the Association of Tumor Necrosis Factor Promoter Polymorphism with Type 2 Diabetic Nephropathy.
Emara M; El-Edel R; Fathy WM; Aboelkhair NT; Watany MM; Abou-Elela DH
Mediators Inflamm; 2020; 2020():1498278. PubMed ID: 32684830
[TBL] [Abstract][Full Text] [Related]
8. Analysis of circulating lncRNA expression profiles in patients with diabetes mellitus and diabetic nephropathy: Differential expression profile of circulating lncRNA
.
Yang Y; Lv X; Fan Q; Wang X; Xu L; Lu X; Chen T
Clin Nephrol; 2019 Jul; 92(1):25-35. PubMed ID: 31079598
[TBL] [Abstract][Full Text] [Related]
9. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serum meteorin-like concentrations with diabetic nephropathy.
Wang R; Hu D; Zhao X; Hu W
Diabetes Res Clin Pract; 2020 Nov; 169():108443. PubMed ID: 32946852
[TBL] [Abstract][Full Text] [Related]
11. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
[TBL] [Abstract][Full Text] [Related]
12. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
13. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
14. Association of Circulating Vitamin D, VDBP, and Vitamin D Receptor Expression with Severity of Diabetic Nephropathy in a Group of Saudi Type 2 Diabetes Mellitus Patients.
Fawzy MS; Beladi FIA
Clin Lab; 2018 Oct; 64(10):1623-1633. PubMed ID: 30336516
[TBL] [Abstract][Full Text] [Related]
15. Decreased serum myonectin concentrations in diabetic nephropathy patients.
Zhang J; Hu W; Lin P; Wang R
Clin Exp Med; 2020 Nov; 20(4):601-607. PubMed ID: 32852729
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella N; George S
Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
[TBL] [Abstract][Full Text] [Related]
17. Serum Irisin and Diabetic Nephropathy in Patients with Diabetes Mellitus.
Kawada T
Horm Metab Res; 2021 Dec; 53(12):825. PubMed ID: 34891213
[TBL] [Abstract][Full Text] [Related]
18. Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus.
Li M; Fan R; Peng X; Huang J; Zou H; Yu X; Yang Y; Shi X; Ma D
Front Endocrinol (Lausanne); 2021; 12():695750. PubMed ID: 34603198
[TBL] [Abstract][Full Text] [Related]
19. Potential serum biomarkers for early detection of diabetic nephropathy.
Motawi TK; Shehata NI; ElNokeety MM; El-Emady YF
Diabetes Res Clin Pract; 2018 Feb; 136():150-158. PubMed ID: 29253627
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of hsa-miR-152-3p are associated with diabetic nephropathy in patients with type 2 diabetes.
Roux M; Perret C; Feigerlova E; Mohand Oumoussa B; Saulnier PJ; Proust C; Trégouët DA; Hadjadj S
Nephrol Dial Transplant; 2018 Dec; 33(12):2201-2207. PubMed ID: 29361146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
